Results 131 to 140 of about 25,748 (208)

PPARa-FSP1 axis modulates lipid peroxidation-induced neuronal ferroptosis to promote functional recovery in mouse model of traumatic spinal cord injury. [PDF]

Cell Mol Life Sci
Song Y, Ding W, Liu Z, Xu X, Zhao B, Zhu Z, Chen H, Song Z, Liu J.   +8 more
europepmc   +1 more source

Drug-induced renal function deterioration in a patient with polyarteritis nodosa. [PDF]

Farm Comunitarios
Iturgoyen-Fuentes DP.
europepmc   +1 more source

Hepatic-vascular crosstalk via GRK2: fenofibrate improves endothelial function by restoring lipid metabolism and NO signaling in obese mice. [PDF]

Front Physiol
Taguchi K, Yonaiyama H, Furukawa T, Matsumoto T, Kobayashi T.   +4 more
europepmc   +1 more source

Handbook of drug-nutrient interactions [PDF]

, 2009

core   +1 more source

GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus. [PDF]

Case Rep Endocrinol
Lai ST, Chan SS, Yu SCY, Cheng JYK, Tsui KT, Ho CA, Yau HC.   +6 more
europepmc   +1 more source

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk? [PDF]

Arch Med Sci
Toth PP, Banach M, International Lipid Expert Panel (ILEP).   +2 more
europepmc   +1 more source

Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes? [PDF]

J Res Med Sci
Chitsazi MR, Safari F, Malekpour E, Mirzaei SA, Shafieyoun MH, Golafshan F, Rouzbahani H, Nekookhoo M, Noursina A, Siavash M.   +9 more
europepmc   +1 more source

Long-acting fenofibrate-loaded microparticles for treating retinal disorders. [PDF]

Int J Pharm
Poudel S, Cui Y, Meng T, Liang W, Zhou K, Cheng R, Zhao L, Yuan T, Kaffash E, Halquist MS, Ma JX, Xu Q.   +11 more
europepmc   +1 more source

Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Kim JY, Kim NH, Lee J, Kim DH, Kim SG.
europepmc   +1 more source

Fenofibrate differentially activates PPARα-mediated lipid metabolism in rat kidney and liver. [PDF]

Sci Rep
Pannala VR, Balik-Meisner MR, Mav D, Phadke DP, Scholl EH, Shah RR, Casey W, Auerbach SS, Wallqvist A.   +8 more
europepmc   +1 more source